INTRODUCTION
The objective of the symposium is to educate the oncology community on the rapidly evolving field of breast cancer from molecular biology to the development and clinical application of highly specific molecules to interfere with the cellular machinery allowing the cancer cells to survive, proliferate, and spread. These certified CME/CE enduring video archives with panel discussions provide access to the conference including clinical presentation and interactive panel discussions with the faculty and audience.
Release Date: May 16, 2019
Expiration Date: April 30, 2020
TARGET AUDIENCE
This activity is intended for healthcare providers actively involved in the treatment and management of patients with breast cancer. This can include MDs/DOs, PAs, NPs, and registered nurses.
LEARNING OBJECTIVES
After completing this activity, the participant will demonstrate the ability to:
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Review all modules associated with this course.
- Successfully complete the post-test (70% accuracy).
- Complete the CME/CE evaluation.
- The estimated time to complete this activity is 4.5 hours.
- Upon successful completion, your CME/CE certificate will be available to print for your records. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.
ACCREDITATION STATEMENTS
The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education accredits the Johns Hopkins University School of Medicine
for physicians.
PHYSICIANS
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER CREDITS
AMERICAN NURSES CREDENTIALING CENTER
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
NOTICE ABOUT OFF-LABEL USE PRESENTATIONS
The Johns Hopkins University School of Medicine/ABCS may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.
The Johns Hopkins University School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.
FULL DISCLOSURE POLICY AFFECTING CME/CE ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Aditya Bardia, MD
Consulting Fee: Biotheranostics
Principal Investigator: Genentech, Inc., Immunomedics, Merck and Company, Inc., Mersana Therapeutics, Inc., Novartis AG, Pfizer, Inc. , Radius Health and Sanofi-Aventis
Rodolfo Bordoni, MD
None to disclose
Melissa Camp, MD, MPH
None to disclose
Cesar Santa-Maria, MD, MSCI
Advisory Board: Genomic Health, Halozyme, Polyphor
Principal Investigator: Pfizer, Inc. and TESARO Biopharmaceutical
Debasish Tripathy, MD
Consulting Fee: Novartis AG and Pfizer, Inc.
Principal Investigator: Novartis AG
No other individual in a position to control the content of this activity has indicated that they have any financial interests or relationships with a commercial entity.
DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
NOTE
Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
OPINIONS AND OFF-LABEL DISCUSSIONS
In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.
CONFIDENTIALITY DISCLAIMER FOR CME/CE ACTIVITY PARTICIPANTS
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.
For CME Questions, please contact the CME Office (410) 502-9636 or e-mail cmenet@jhmi.edu. For CME Certificates, please call (410) 502-9636.
Johns Hopkins University School of Medicine, Office of Continuing Medical Education, Turner 20/720 Rutland Avenue, Baltimore, Maryland 21205-2195. Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03) (Updated 4/09 and 3/14)
COPYRIGHT INFORMATION
2019 © All rights reserved - The Johns Hopkins University School of Medicine.
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without prior written permission.
To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com.
HARDWARE/SOFTWARE REQUIREMENTS
Computer:
- Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
- Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
- Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.
Software/Browser:
- Windows XP or above running Internet Explorer 7 (service pack 2) or above.
- MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
- A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.
Mobile Device:
- Any Apple iPad or iPad Mini running iOS 5 or above.
- Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by independent educational grants from AstraZeneca, Eisai and Novartis.